Orion.fi

Orion is building a unique pharmaceutical research …

WEBORION CORPORATION PRESS RELEASE 30 March 2023 at 9.30 EEST. Start page Newsroom All news Orion is building a unique pharmaceutical research …

Actived: 3 days ago

URL: https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2023/orion-is-building-a-unique-pharmaceutical-research-ecosystem-in-finland--using-data-and-artificial-intelligence-to-shorten-the-development-time-of-new-innovative-medicines/

Orion is known for taking good care of its employees’ …

WEBThe promotion of mental well-being in the workplace is evident at every level: guidelines, practical measures and a culture of open discussion. The key priority is to detect …

Category: Health Go Health

Orion and Propeller Health partner to bring new digital …

WEBOrion Corporation Press release 11 February 2019 at 4.00 p.m. EET. Orion Corporation and Propeller Health, a leading digital therapeutics company, today …

Category: Health Go Health

Orion Corporation and Newel Health enter into licensing …

WEBOrion Corporation (“Orion”) and Newel Health (“Newel”) have entered into a license agreement regarding ODD-403 (“Rohkea”), a digital therapeutic (DTx) developed …

Category: Health Go Health

Secondary use of health data benefits society as a whole

WEBIt is possible to utilise extensive health datasets, such as the widely known Kanta system, in secondary use, i.e. outside the original purpose for which they were …

Category: Health Go Health

Disposal of pharmaceutical waste

WEBThe correct and safe way to dispose of pharmaceutical waste is returning it to a pharmacy. Pharmacies accept household pharmaceutical waste without charge. Pharmacies deliver …

Category: Health Go Health

Orion enters into exclusive agreement with Jemincare for novel …

WEBOrion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclusive global development and commersialisation rights, excluding …

Category: Health Go Health

Orion Group Half-Year Financial Report 1–6/2023

WEBPresident and CEO Liisa Hurme: The year has progressed mostly in line with our expectations despite slight headwinds with certain markets and timing of deliveries …

Category: Health Go Health

Orion Animal Health receives FDA approval for Bonqat® …

WEBOrion Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Bonqat® (pregabalin oral solution) for alleviation of acute anxiety …

Category: Food Go Health

Orion Acquires Inovet’s Animal Health Business

WEBORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 15 June 2022 at 9.30 EEST. Orion Corporation (“Orion”) has entered into an agreement …

Category: Health Go Health

Financial Statement documents

WEBFor more than a century, Orion has been building well-being by providing effective medical treatments. Our drugs have been used to eliminate national diseases, prevent heart …

Category: Medical Go Health

Orion Animal Health’s Bonqat® (pregabalin) receives positive …

WEBNiclas Lindstedt, Vice President, Orion Animal Health, Orion Corporation. tel. +358 10 426 4116. Publisher: Orion Corporation. Communications. Orionintie 1A, FI …

Category: Health Go Health

The acquisition of Inovet’s animal health business V.M.D. NV

WEBThis presentation contains forward-looking statements which involve risks and uncertainty factors. These statements are not based on historical facts but relate to the Company’s …

Category: Health Go Health

Generics and Consumer Health

WEB10% 20% 30% 40% 50% 60% 70% 0 100 200 300 400 500 600 MEUR Net sales (Specialty Products unit 2011-2022) Share of Orion's net sales (*2022 w/o MEUR 228 milestone)

Category: Health Go Health